Chemical Genomics Centre, Max Planck Institute of Molecular Physiology, Dortmund, 44227, Germany; Department of Chemical Biology, Max Planck Institute of Molecular Physiology, Dortmund, 44227, Germany; Faculty of Chemistry and Chemical Biology, TU Dortmund, Otto-Hahn Strasse 6, Dortmund, 44227, Germany.
Chemical Genomics Centre, Max Planck Institute of Molecular Physiology, Dortmund, 44227, Germany; Department of Chemical Biology, Max Planck Institute of Molecular Physiology, Dortmund, 44227, Germany; Faculty of Chemistry and Biochemistry, Ruhr-University Bochum, Universitätstr. 150, Bochum, 44780, Germany.
Eur J Med Chem. 2022 Jan 15;228:114014. doi: 10.1016/j.ejmech.2021.114014. Epub 2021 Dec 2.
Inhibition of the RNA-binding protein LIN28 and disruption of the protein-RNA interaction of LIN28-let-7 with small molecules holds great potential to develop new anticancer therapeutics. Herein, we report the LIN28 inhibitory activities of a series of 30 small molecules with a tricyclic tetrahydroquinoline (THQ)-containing scaffold obtained from a Povarov reaction. The THQ molecules were structurally optimized by varying the 2-benzoic acid substituent, the fused ring at 3- and 4-positions, and the substituents at the phenyl moiety of the tetrahydroquinoline core. Among the tested compounds, GG-43 showed dose-dependent inhibition in an EMSA validation assay and low micromolar inhibitory activity in a fluorescence polarization-based assay measuring disruption of LIN28-let-7 interaction. Binding mode between GG-43 and the cold shock domain of LIN28 was proposed via a molecular docking analysis. The study provides one of the first systematic analyses on structural features that are required for LIN28 inhibition, and indicates the necessity to develop small molecules with new scaffolds as LIN28-targeting probes and therapeutic candidates. In parallel, this study demonstrates the polypharmacological nature of tricyclic THQ-containing scaffolds accessible through Povarov reactions.
RNA 结合蛋白 LIN28 的抑制作用以及小分子对 LIN28-let-7 蛋白-RNA 相互作用的破坏,具有开发新型抗癌治疗方法的巨大潜力。在此,我们报告了一系列 30 种小分子对 Povarov 反应得到的含三环四氢喹啉 (THQ) 骨架的 LIN28 抑制活性。通过改变 2-苯甲酸取代基、3-和 4-位的稠合环以及四氢喹啉核心的苯基取代基,对 THQ 分子进行了结构优化。在所测试的化合物中,GG-43 在 EMSA 验证测定中表现出剂量依赖性抑制作用,并且在基于荧光偏振测定的测定中,LIN28-let-7 相互作用的破坏具有低微摩尔抑制活性。通过分子对接分析提出了 GG-43 与 LIN28 的冷休克结构域之间的结合模式。该研究提供了对 LIN28 抑制所需结构特征的首次系统分析之一,并表明有必要开发具有新骨架的小分子作为 LIN28 靶向探针和治疗候选物。同时,这项研究证明了通过 Povarov 反应获得的含三环 THQ 骨架的多效性。